Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Molecular and Cellular Biology|April 3, 2004
How many mutant p53 molecules are needed to inactivate a tetramer?Wan Mui Chan, Wai Yi Siu, Anita Lau, et al.The Journal of Biological Chemistry|July 18, 2002
Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclinsTsz Kan Fung, Wai Yi Siu, Cain H Yam, et al.FEBS Letters|August 5, 2006
Polyploidization increases the sensitivity to DNA-damaging agents in mammalian cellsPok Man Hau, Wai Yi Siu, Nathalie Wong, et al.Developmental Neurorehabilitation|September 6, 2012
Studies comparing the efficacy of constraint-induced movement therapy and bimanual training in children with unilateral cerebral palsy: a systematic reviewVicky An-Qin Dong, Ivy Hsi-Hsuan Tung, Hester Wai-Yi Siu, et al.Cancer Research|February 21, 2006
Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathwaysChui Chui Ho, Wai Yi Siu, Anita Lau, et al.FEBS Letters|October 24, 2003
ING1b decreases cell proliferation through p53-dependent and -independent mechanismsFan Cheung Tsang, Lai See Po, Ka Man Leung, et al.Molecular Cancer Research : MCR|February 1, 2006
Ubiquitination of p53 at multiple sites in the DNA-binding domainWan Mui Chan, Man Chi Mak, Tsz Kan Fung, et al.Molecular Cancer Therapeutics|May 14, 2004
Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanismsWai Yi Siu, Anita Lau, Talha Arooz, et al.The Journal of Biological Chemistry|December 19, 2003
Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domainsChuen-Pei Ng, Hung Chiu Lee, Chung Wai Ho, et al.Cancer Research|September 5, 2002
The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2Ka Man Leung, Lai See Po, Fan Cheung Tsang, et al.Pageof 2